BioTuesdays

Texas A&M video series features iBio COVID-19 vaccines

iBio Inc.

iBio’s (NYSE American:IBIO) two COVID-19 vaccine candidates were featured on the final episode of the video series, “COVID-19: The Texas A&M University System Responds.”

“This is an important collaboration,” John Sharp, chancellor of Texas A&M, said in the video. “It’s an example of how our scientists, engineers and other experts collaborate with the private sector on the world’s most pressing problems.”

iBio produces its two COVID-19 vaccine candidates in modified tobacco leaves using a plant-based growing system it calls FastPharming. The company says its system can produce vaccine doses at mass commercial scale more quickly than other methods.

A team of scientists at Texas A&M expect to see preliminary results before Oct. 1 from preclinical trials in mice.

The Texas A&M video can be viewed here:

Sign up for the BioTuesdays weekly newsletter

Get the latest news on the healthcare industry’s corporate and clinical developments, executive moves, and market updates. Every Tuesday, in your inbox.